Search Results
Sep 08, 2026, 09:18 ET Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business
conditions. Additional information appears in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F filed on April 1, 2026. Forward-looking statements speak only as of the date of this press release. Except as required by law, the Company undertakes
More news about: Scinai Immunotherapeutics Ltd.
Sep 08, 2026, 09:09 ET An Icon Is Born: PLAYA DIA Launches With a New Vision of Luxury Tequila
it because of the burn."DESIGNED TO BE DISPLAYEDAt the center of the brand is its all-glass seashell bottle, a sculptural white form accented with turquoise rope and details drawn from luxury coastal design, built to look unlike anything else on the tequila shelf. PLAYA DIA is also
More news about: PLAYA DIA
Sep 08, 2026, 09:05 ET Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials
Report on Form 10-K under the heading RISK FACTORS and in the company's other filings with the SEC. The information in this press release should be read in conjunction with a review of the company's filings with the SEC including the information in the company's most recent Annual Report on Form 10-K under
More news about: Labcorp
Sep 08, 2026, 09:00 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 25, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," Paramount's most recently filed Quarterly Report on Form 10-Q for the quarter
More news about: Paramount Skydance Corporation
Sep 08, 2026, 09:00 ET SuperCom Expands into 20th New U.S. State with New Electronic Monitoring Contract in Illinois
statements and in the section captioned "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC") on April 28, 2026, our reports on Form 6-K filed from time to time with the SEC and our other filings with the SEC.
More news about: SuperCom
Sep 08, 2026, 09:00 ET Orphalan Initiates Global Phase 3 TRADITiONAL Study of Investigational Once-Daily Trientine Therapy in Wilson Disease
rare diseases, including Wilson disease. The company's portfolio has recently expanded to include infantile epileptic spasms syndrome (IESS), a rare form of paediatric epilepsy, as well as neuro-oncology, focusing on conditions with significant unmet medical need. By combining scientific rigor with a
More news about: Orphalan
Sep 08, 2026, 09:00 ET Subsidiary of Greenland Technologies Receives Government Incentive Program Approvals for Its Heavy Electric Industrial Vehicles
rights, supply chain conditions, and other risks detailed in the Company's filings with the Securities and Exchange Commission, including the Company's Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on March 23, 2026. Greenland undertakes no obligation
More news about: Greenland Technologies Holding Corporation
Sep 08, 2026, 09:00 ET Gen Named One of Fast Company's Best Workplaces for Innovators
and how can we help solve it?When researchers and product teams identify a threat, a gap, a pain point, they have the freedom to act. Teams form, organize around the opportunity and build the customer case, not just the business case. With access to the tools, data and cross-functional support
More news about: Gen Digital Inc.
Sep 08, 2026, 09:00 ET Cambium Launches Breakthrough Laser Eye Protection for Commercial and Private Pilots
532nm laser exposureScratch-resistant lens performanceDazzle-angle agnostic protectionPrescription-compatible formatsForm-factor agnostic designCambium would like to acknowledge the multitude of valuable contributions from the BioMADE team that helped support
More news about: Cambium Biomaterials, Inc
Sep 08, 2026, 09:00 ET The V Foundation for Cancer Research Awards $1.8 Million in Grants to Children's Hospital of Philadelphia Researchers
Grant to develop a novel chimeric antigen receptor (CAR) T-cell therapy for children with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive form of blood cancer.
More news about: Children's Hospital of Philadelphia
Sep 08, 2026, 09:00 ET Global Genes Partners with Citizen Health to Power RARE-X
spent years building an instrument library specifically for rare diseases, capturing symptom severity, progression and burden of illness in structured form, including validated instruments and custom surveys. Citizen Health can retrieve participants' medical records from more than 4,000 U.S. institutions
More news about: Global Genes
Sep 08, 2026, 09:00 ET THE MEXICO FUND, INC. ANNOUNCES THE STRENGTHENING AND RENEWAL OF ITS EXPENSE LIMITATION AGREEMENT AND DECLARES DISTRIBUTION
Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report the distribution for federal income tax purposes. CONTACT:Tofi
More news about: The Mexico Fund, Inc.
Sep 08, 2026, 09:00 ET Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order
and external factors, such as drugs, diet, lifestyle, and the microbiome, on human health. By measuring thousands of discrete chemical signals that form biological pathways in the body, metabolomics can reveal important biomarkers, enabling a better understanding of a drug's mechanism of action, pharmacodynamics,
More news about: Metabolon, Inc.
Sep 08, 2026, 09:00 ET Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order
and external factors, such as drugs, diet, lifestyle, and the microbiome, on human health. By measuring thousands of discrete chemical signals that form biological pathways in the body, metabolomics can reveal important biomarkers, enabling a better understanding of a drug's mechanism of action, pharmacodynamics,
More news about: Metabolon, Inc.
Sep 08, 2026, 09:00 ET IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does
More news about: Amgen
Sep 08, 2026, 08:50 ET Shareholders who lost money in shares of Innventure, Inc. (NASDAQ: INV) should contact Wolf Haldenstein Immediately
materialize.On August 13, 2026, Innventure said it was suspending its previously communicated 2026 Accelsius revenue and cash-flow expectations. Its Form 10-Q filed with the U.S. Securities and Exchange Commission stated that the DarkNX deployment site was no longer available and the project had been
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Sep 08, 2026, 08:45 ET VineBrook Homes Trust Announces Tender Offer for up to $30 million, or 909,090 Shares, of its Class A Common Stock
described in greater detail in the Company's filings with the SEC, particularly those described in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company's other filings
More news about: VineBrook Homes Trust, Inc.
Sep 08, 2026, 08:40 ET From Ancient Wolf Legends to Modern Surnames, New Book Traces the Origins of "Wilk"-root Family Names
BookAuthority ranked as its No. 1 etymology book in 2021. Traditional surname references generally trace Wilkinson and related names to a shortened form of William, with "-kin" used as a diminutive suffix that developed in Middle English. Wilkinson offers an alternative theory: that many Wilk-root names
More news about: Archway Publishing
Sep 08, 2026, 08:30 ET As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen
contact with the skin, releasing moisture in the form of micro-droplets.Most conventional water-drop formulations have long faced structural stability challenges in sunscreens. Over time, ingredients can separate, and microscopic cracks can form in the UV-protective film, significantly degrading
More news about: Kolmar Korea
Sep 08, 2026, 08:30 ET As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen
contact with the skin, releasing moisture in the form of micro-droplets.Most conventional water-drop formulations have long faced structural stability challenges in sunscreens. Over time, ingredients can separate, and microscopic cracks can form in the UV-protective film, significantly degrading
More news about: Kolmar Korea
Sep 08, 2026, 08:30 ET Angesichts immer heftigerer Hitzewellen weltweit bringt Kolmar Korea innovative Kühltechnologie in Sonnenschutzprodukte
Paradebeispiel hierfür ist die firmeneigene „Water-Drop"-Technologie, bei der sich die Partikelstruktur beim Kontakt mit der Haut auflöst und Feuchtigkeit in Form von Mikrotröpfchen freisetzt.Die meisten herkömmlichen Wassertropfen-Formulierungen hatten in Sonnenschutzmitteln lange Zeit mit Problemen hinsichtlich
More news about: Kolmar Korea
Sep 08, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of $15.7 Billion
described above and in the Risk Factors section of the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025 filed with the SEC on November 21, 2025, the Company's Quarterly Reports on Form 10-Q, and the Company's other filings with the SEC, as amended or updated from time
More news about: Bitmine Immersion Technologies, Inc.
Sep 08, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of $15.7 Billion
described above and in the Risk Factors section of the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025 filed with the SEC on November 21, 2025, the Company's Quarterly Reports on Form 10-Q, and the Company's other filings with the SEC, as amended or updated from time
More news about: Bitmine Immersion Technologies, Inc.
Sep 08, 2026, 08:15 ET Columbia Banking System to Present at the Barclays Global Financial Services Conference
statements. Readers are encouraged to read the SEC reports of Columbia, particularly its Annual Report on Form 10-K for the Fiscal Year ended December 31, 2025 and its Quarterly Reports on Form 10-Q for the three months ended March 31, 2026 and June 30, 2026, for meaningful cautionary language discussing
More news about: Columbia Banking System, Inc.
Sep 08, 2026, 08:14 ET Anitoa Announces Secure Cloud Connectivity for its Portable qPCR Instruments, Unlocking Advanced Biosurveillance and AI Integration
instruments eliminate the need for cumbersome, traditional laboratory equipment. Their remarkable performance, low power consumption, and calibration-free form factor are entirely powered by Anitoa's own proprietary ultra-low-light CMOS bioimaging sensor. By combining this cutting-edge optical technology with
More news about: Anitoa Systems, LLC